Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?

Research output: Contribution to journal › Editorial (Academic Journal)

Original language	English
Pages (from-to)	134-135
Number of pages	2
Journal	European Urology
Early online date	10 Feb 2016
DOIs	https://doi.org/10.1016/j.eururo.2016.01.052
Publication status	Published - Jul 2016

Structured keywords

Centre for Surgical Research

Access to Document

10.1016/j.eururo.2016.01.052

Cite this

@article{d0a791d5511c47e88508277d40d62c01,

title = "Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?",

author = "Marcus Drake",

year = "2016",

month = jul,

doi = "10.1016/j.eururo.2016.01.052",

language = "English",

pages = "134--135",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Do the Benefits of Phosphodiesterase Type 5 Inhibitors in Male Lower Urinary Tract Symptoms Go Beyond Improved Symptoms?

AU - Drake, Marcus

PY - 2016/7

Y1 - 2016/7

U2 - 10.1016/j.eururo.2016.01.052

DO - 10.1016/j.eururo.2016.01.052

M3 - Editorial (Academic Journal)

C2 - 26874807

SP - 134

EP - 135

JO - European Urology

JF - European Urology

SN - 0302-2838

ER -